India’s FMCG brands brace for tighter scrutiny of food claims and front-of-pack labels
Rising regulatory scrutiny of misleading food claims, alongside proposed warning labels for unhealthy packaged foods, could force FMCG companies to rethink packaging, marketing and claim substantiation while increasing quality-control investment.
What happened
Indian FMCG brands · Indian regulators are increasing scrutiny of misleading food claims, while proposed front-of-pack warning labels for unhealthy packaged
Why this matters
Acquirers should diligence target product claims, nutritional exposure, packaging-change costs and regulatory capabilities, as compliance liabilities may reshape valuations in India’s FMCG sector.
What to watch
- Final FSSAI notification defining front-of-pack label format, nutrient thresholds, category exemptions, and transition periods.
- Volume and severity of FSSAI, state food-safety, ASCI, or consumer-court actions involving food and beverage claims.
- Mandatory recall, delisting, relabeling, or corrective-advertising orders against major packaged-food brands.
- Large retailers and marketplaces requiring claim substantiation, nutrition data, or compliance certifications from suppliers.
- Accelerating reformulation announcements, pack changes, or marketing-language withdrawals in biscuits, snacks, beverages, breakfast foods, dairy, and children’s products.
- Consumer and media attention shifting from individual misleading claims to broad scrutiny of ultra-processed foods and high sugar/salt categories.
- Audit all nutrition, wellness, natural, immunity, protein, sugar, and child-focused claims against product-level evidence and applicable FSSAI rules.
- Build a central claim-substantiation repository linking marketing copy, ingredient specifications, laboratory tests, and legal approvals.
- Prioritize reformulation and pack redesign for high-revenue SKUs with elevated sugar, salt, or fat exposure and health-positioning risk.
- Create compliant fallback artwork and e-commerce product-page copy to reduce disruption from regulator notices.
- Increase quality-control, supplier-traceability, and third-party testing budgets; use these investments as a trust signal with modern trade and digital retailers.
- Review promotional mechanics and influencer campaigns, where implied health claims may create liability even if pack language is compliant.
- Use portfolio architecture to shift growth investment toward transparently positioned products, smaller portions, and better-for-you adjacencies.